News for GoodRx Holdings, Inc. (GDRX)

GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the 13 Best Healthcare Stocks to Buy Under $10. On June 13, Leerink Partners analyst Michael Cherny maintained a bullish stance on GoodRx Holdings, Inc. (NASDAQ:GDRX), giving the stock a Buy rating with a $7 price target. The analyst based the rating on the company’s potential for growth and strategic […]

Summary GoodRx Holdings Inc (GDRX), a prominent platform for medication savings in the U.S., has announced that it will release its financial results for the se

[url="]GoodRx Holdings, Inc.[/url] (Nasdaq: GDRX) (”œGoodRx” or the ”œCompany”), the leading platform for medication savings in the U.S., today announced

GoodRx (GDRX) to announce Q2 2025 earnings results on August 6, 2025, after market close. The conference call and webcast are scheduled for August 7, 2025,

GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the 10 best-value penny stocks to buy, according to analysts. On June 6, the company launched Lifecycle, a development tool designed to improve team velocity, streamline review workflows, and reduce infrastructure overhead. The tool enables engineering, quality control, and platform teams to automatically create temporary, isolated environments for […]

GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the 11 Best US Stocks to Invest in Under $5. On May 14, KeyBanc Capital Markets reiterated an “Overweight” rating on GoodRx Holdings, Inc. (NASDAQ:GDRX) with a price target of $6. KeyBanc’s analyst, Scott Schoenhaus, highlighted the current position of GoodRx Holdings, Inc. (NASDAQ:GDRX) within the challenging retail […]

GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 10, GoodRx Holdings, Inc. (NASDAQ:GDRX) announced launching a new subscription service focused on erectile dysfunction (ED) treatment. The new service aims to innovate access to ED care by addressing common barriers such as high costs, social stigma, long […]

GoodRx launches a new subscription service for erectile dysfunction treatments, potentially boosting its stock value. Analysts forecast a promising 44.1

GoodRx (GDRX) has unveiled a groundbreaking subscription service aimed at addressing erectile dysfunction (ED). This innovative offering seeks to eliminate typi

Applied Materials (AMAT) to hold fiscal Q2 2025 earnings call on May 15, 2025. GoodRx (GDRX) launches Community Link for independent pharmacies. Both

We recently published a list of Jim Cramer’s Thoughts on These 12 Stocks. In this article, we are going to take a look at where GoodRx Holdings, Inc. (NASDAQ:GDRX) stands against other stocks that Jim Cramer discusses. Noting that Cramer has not said anything about GoodRx Holdings, Inc. (NASDAQ:GDRX) in a long time, a caller […]

On May 13, 2025, UBS analyst Kevin Caliendo updated his outlook on GoodRx Holdings (GDRX), a prominent player in the healthcare technology sector. The analyst h

Total Revenue: $203 million, up 3% year-over-year.Prescription Transactions Revenue: Increased by 2% year-over-year.Manufacturer Solutions Revenue: Increased b

May 08, 2025 / 12:00PM GMTOperator Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx first quarter 2025 earnings call. As a reminder, t

GoodRx (GDRX) delivered earnings and revenue surprises of 0% and 0.19%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Discover what to expect as GoodRx (GDRX) announces Q1 earnings. Get insights into EPS, revenue estimates, and past performance.

GoodRx (GDRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wells Fargo has revised its price target for GoodRx (GDRX), lowering it from $8 to $7, while maintaining an Overweight rating on the stock. The firm recognizes

We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to take a look at where GoodRx Holdings, Inc.